Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Ho

Showing results (211-220 of 321) with videos related to

Pageof 33
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2001
Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasoneG Egerer, U Hegenbart, H Salwender, et al.
Bone Marrow Transplantation|November 18, 2000
Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myelomaF W Cremer, E Ehrbrecht, K Kiel, et al.
Scandinavian Journal of Rheumatology|April 28, 2006
Musculoskeletal and neuropsychiatric manifestations are the main source of persisting affection and organ damage in a German population of patients with systemic lupus erythematosusC Fiehn, A Wilmes, R Max, et al.
Leukemia|November 13, 2013
Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphomaS Dietrich, J Weidle, M Rieger, et al.
Leukemia|August 1, 1990
Long-term effects of 2'-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemiaA D Ho, D N Männel, G Wulf, et al.
Journal of Leukocyte Biology|April 26, 2003
Imatinib restores expression of CD62L in BCR-ABL-positive cellsS Fruehauf, J Topaly, M Schad, et al.
Blood|July 1, 1988
Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factorA Kist, A D Ho, U Räth, et al.
British Journal of Haematology|August 25, 1999
Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantationC Rottenburger, K Kiel, T Bösing, et al.
Experimental Hematology|May 1, 1996
Cell-cycle kinetics and VSV-G pseudotyped retrovirus-mediated gene transfer in blood-derived CD34+ cellsY P Agrawal, R S Agrawal, A M Sinclair, et al.
British Journal of Cancer|October 1, 1989
Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factorD N Männel, A Kist, A D Ho, et al.
Pageof 33

Showing results (211-220 of 321) with videos related to

Sort By:
Pageof 33
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2001
Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasoneG Egerer, U Hegenbart, H Salwender, et al.
Bone Marrow Transplantation|November 18, 2000
Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myelomaF W Cremer, E Ehrbrecht, K Kiel, et al.
Scandinavian Journal of Rheumatology|April 28, 2006
Musculoskeletal and neuropsychiatric manifestations are the main source of persisting affection and organ damage in a German population of patients with systemic lupus erythematosusC Fiehn, A Wilmes, R Max, et al.
Leukemia|November 13, 2013
Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphomaS Dietrich, J Weidle, M Rieger, et al.
Leukemia|August 1, 1990
Long-term effects of 2'-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemiaA D Ho, D N Männel, G Wulf, et al.
Journal of Leukocyte Biology|April 26, 2003
Imatinib restores expression of CD62L in BCR-ABL-positive cellsS Fruehauf, J Topaly, M Schad, et al.
Blood|July 1, 1988
Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factorA Kist, A D Ho, U Räth, et al.
British Journal of Haematology|August 25, 1999
Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantationC Rottenburger, K Kiel, T Bösing, et al.
Experimental Hematology|May 1, 1996
Cell-cycle kinetics and VSV-G pseudotyped retrovirus-mediated gene transfer in blood-derived CD34+ cellsY P Agrawal, R S Agrawal, A M Sinclair, et al.
British Journal of Cancer|October 1, 1989
Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factorD N Männel, A Kist, A D Ho, et al.
Pageof 33